AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 287: L191-L200, 2004. First published February 13, 2004; doi:10.1152/ajplung.00284.2003
1040-0605/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/1/L191    most recent
00284.2003v2
00284.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newman, D. R.
Right arrow Articles by Sannes, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newman, D. R.
Right arrow Articles by Sannes, P. L.

Heparin affects signaling pathways stimulated by fibroblast growth factor-1 and -2 in type II cells

Donna R. Newman, Cheng-Ming Li, Rebecca Simmons, Jody Khosla, and Philip L. Sannes

Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina 27606

Submitted 21 August 2003 ; accepted in final form 9 February 2004

Undersulfation of the basement membrane matrix of alveolar type II (AT2) cells compared with that of neighboring type I cells is believed to account for some of the known morphological and functional differences between these pneumocytes. Heparin, a model for sulfated components of basement membrane matrices, is known to inhibit fibroblast growth factor (FGF)-2-stimulated DNA synthesis as well as gene expression of FGF-2 and its receptor in AT2 cells. To determine whether these end points result from specific effects of heparin on FGF-related signaling pathways, isolated rat AT2 cells were treated with 100 ng/ml FGF-1 or FGF-2 in the presence of up to 500 µg/ml heparin. In addition, experiments were done on cells grown in the presence of 20 mM sodium chlorate (sulfation inhibitor). High-dose heparin reduced FGF-1- or FGF-2-stimulated phosphorylation of mitogen-activated protein kinase kinases (MEK1/2), p44/42 mitogen-activated protein kinases (MAPK/ERK1/2), stress-activated protein kinase/c-Jun NH2-terminal kinase, Akt/protein kinase B, and p90RSK. FGF-2-stimulated signaling was more sensitive to heparin's effects than was signaling stimulated by FGF-1. Heparin had an additive effect on the reduced [3H]thymidine incorporation in FGF-2-treated AT2 cells caused by inhibition of the MEK/ERK pathway by the MEK inhibitor PD-98059. The data suggest that heparin's known capacity to alter DNA synthesis and, possibly, other biological end points is realized via cross talk between multiple signaling pathways.

extracellular matrix; basement membrane; receptor tyrosine kinase phosphorylation; ERK pathway; fibroblast growth factor signaling


Address for reprint requests and other correspondence: P. L. Sannes, Dept. of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State Univ., 4700 Hillsborough St., Raleigh, NC 27606 (E-mail: philip_sannes{at}ncsu.edu).




This article has been cited by other articles:


Home page
 Toxicol SciHome page
H. Jin, S.-H. Chang, C.-X. Xu, J.-Y. Shin, Y.-S. Chung, S.-J. Park, Y.-S. Lee, G.-H. An, K.-H. Lee, and M.-H. Cho
High Dietary Inorganic Phosphate Affects Lung through Altering Protein Translation, Cell Cycle, and Angiogenesis in Developing Mice
Toxicol. Sci., November 1, 2007; 100(1): 215 - 223.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. R. Newman, E. Walsh, K. B. C. Apparao, and P. L. Sannes
Fibroblast growth factor-binding protein and N-deacetylase/N-sulfotransferase-1 expression in type II cells is modulated by heparin and extracellular matrix
Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1314 - L1320.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
K. A. Leiner, D. Newman, C.-M. Li, E. Walsh, J. Khosla, and P. L. Sannes
Heparin and Fibroblast Growth Factors Affect Surfactant Protein Gene Expression in Type II Cells
Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 611 - 618.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
A. Schmidt, D. Ladage, T. Schinkothe, U. Klausmann, C. Ulrichs, F.-J. Klinz, K. Brixius, S. Arnhold, B. Desai, U. Mehlhorn, et al.
Basic Fibroblast Growth Factor Controls Migration in Human Mesenchymal Stem Cells
Stem Cells, July 1, 2006; 24(7): 1750 - 1758.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
T. Ogawa, T. Nikawa, H. Furochi, M. Kosyoji, K. Hirasaka, N. Suzue, K. Sairyo, S. Nakano, T. Yamaoka, M. Itakura, et al.
Osteoactivin upregulates expression of MMP-3 and MMP-9 in fibroblasts infiltrated into denervated skeletal muscle in mice
Am J Physiol Cell Physiol, September 1, 2005; 289(3): C697 - C707.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.